Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2004, for Anthem, Inc. (now Elevance Health). Anthem is a leading health benefits company and an independent licensee of the Blue Cross Blue Shield Association, operating in Indiana, Kentucky, Ohio, Connecticut, New Hampshire, Maine, Colorado, Nevada, and Virginia. As of March 31, 2004, the company served over 12.5 million members. A significant development during this period was the pending merger with WellPoint Health Networks Inc., valued at approximately $16.4 billion, expected to close in mid-2004.
Key Financial Metrics
| Metric | Q1 2004 | Q1 2003 |
|---|---|---|
| Total Operating Revenue | $4,467.9 million | $4,015.9 million |
| Total Revenue (incl. Investment) | $4,574.1 million | $4,100.3 million |
| Net Income | $295.6 million | $191.7 million |
| Diluted EPS | $2.08 | $1.36 |
| Benefit Expense Ratio | 82.1% | 82.2% |
| Administrative Expense Ratio | 17.4% | 17.8% |
| Cash and Cash Equivalents | $686.3 million | $464.5 million (Dec 31, 2003) |
| Total Investments | $7,176.7 million | $6,915.2 million (Dec 31, 2003) |
| Long-Term Debt | $1,663.7 million | $1,662.8 million (Dec 31, 2003) |
| Debt-to-Total-Capital Ratio | 20.8% | 21.7% (Dec 31, 2003) |
Material Changes vs. Prior Period
- Revenue Growth: Total operating revenue increased 11% to $4,467.9 million, driven by an 11% increase in premiums and a 13% increase in administrative fees. Premium growth was fueled by rate increases and higher membership in Small Group and Individual segments.
- Profitability Surge: Net income rose 54% to $295.6 million. This was significantly aided by a $44.8 million tax benefit resulting from new Indiana legislation regarding the high-risk health insurance pool (ICHIA).
- Investment Gains: Net realized gains on investments jumped to $33.0 million from $12.9 million, primarily due to the reallocation of fixed maturity securities to optimize after-tax income.
- Membership Expansion: Total membership grew 9% to 12.5 million. Notable growth occurred in National Accounts (up 17%) and Individual business (up 10%). Self-funded membership increased 14%.
- Cost Trends: The aggregate cost of care trend for the 12 months ended March 31, 2004, was approximately 9.5%, driven by increases in professional and outpatient services.
Guidance, Outlook, and Risks
- Merger with WellPoint: The company anticipates closing the $16.4 billion merger with WellPoint in mid-2004. Anthem has secured a $3.0 billion bridge loan and plans to issue up to $2.0 billion in debt securities to fund the transaction. Cash requirements for the deal are estimated at $3.9 billion.
- Cost Outlook: Management expects aggregate cost of care trends to range from 9.5% to 10.5% in 2004, with pharmacy costs expected to rise due to the expiration of favorable trends from Claritin and hormone replacement therapy studies.
- Tax Rate: The effective tax rate for the quarter was lower due to the one-time Indiana tax benefit. Management expects the effective tax rate to return to the 34% to 35% range for the remainder of 2004.
- Legal Contingencies: Anthem faces numerous class-action lawsuits regarding provider payments and coverage guidelines (e.g., MDL proceedings in Miami, Florida). While the company intends to vigorously defend these, outcomes are uncertain. A significant litigation matter in Ohio was resolved in 2003, resulting in a $24.5 million benefit recognized in the prior year.
- Medicare Legislation: The company has deferred the recognition of the impact of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 pending further accounting guidance.
Investor Verification Checklist
- Merger Closing: Verify the status of regulatory and shareholder approvals for the WellPoint merger, scheduled for a vote on June 28, 2004.
- Tax Benefit Sustainability: Confirm that the $44.8 million tax benefit was a one-time event and review the projected effective tax rate for subsequent quarters.
- Investment Portfolio: Assess the $7.2 billion investment portfolio for potential "other-than-temporary" impairments given market volatility.
- Claim Reserves: Review the adequacy of the $1.925 billion liability for unpaid claims, noting the sensitivity of net income to changes in completion and trend factors.
- Liquidity for Acquisition: Monitor the execution of the $2.0 billion debt issuance and the termination of the $3.0 billion bridge loan upon merger closing.